SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
X	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* AISLING CAPITAL III LP (Last) (First) (Middle) 888 SEVENTH AVENUE 30TH FL (Street) NEW YORK NY 10106 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Durata Therapeutics, Inc. [ DRTX ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 05/20/2014
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/20/2014		J		745,730(1)(2)	D	$0(1)	2,280,175	D(2)(7)
Common Stock	05/20/2014		J		3,528	D	$0	0	D(3)(7)
Common Stock								865	D(4)(7)
Common Stock								3,520	D(5)(7)
Common Stock								1,797	D(6)(7)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* AISLING CAPITAL III LP (Last) (First) (Middle) 888 SEVENTH AVENUE 30TH FL (Street) NEW YORK NY 10106 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Aisling Capital Partners III LLC (Last) (First) (Middle) 888 SEVENTH AVENUE 30TH FL (Street) NEW YORK NY 10106 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Aisling Capital Partners III LP (Last) (First) (Middle) 888 SEVENTH AVENUE 30TH FL (Street) NEW YORK NY 10106 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* SCHIFF ANDREW N (Last) (First) (Middle) 888 SEVENTH AVENUE 30TH FL (Street) NEW YORK NY 10106 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Purcell Dennis J (Last) (First) (Middle) 888 SEVENTH AVENUE 30TH FL (Street) NEW YORK NY 10106 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* ELMS STEVE (Last) (First) (Middle) 888 SEVENTH AVENUE 30TH FL (Street) NEW YORK NY 10106 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. On May 20, 2014, Aisling Capital III, LP ("Aisling") distributed (the "Distribution") 750,000 shares of the Common Stock ("Common Stock") of Durata Therapeutics, Inc. (the "Issuer") pro rata to its partners for no consideration. Certain partners of Aisling, including Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, and Aisling Capital Partners III LLC ("Aisling Partners"), as general partner of Aisling GP, made a subsequent pro rata distribution (the "Subsequent Distribution") of shares received to their respective partners or members for no consideration.

2. The shares are directly held by Aisling and are indirectly held by Aisling GP, Aisling Partners, and each of Steve Elms, Andrew Schiff and Dennis Purcell (collectively, the "Managers"), who are the managing members of Aisling Partners. Aisling GP, Aisling Partners and the Managers share voting and dispositive power over the shares directly held by Aisling. Pursuant to Rule 16a-1(a)(2)(ii)(B) under the Securities Exchange Act of 1934, as amended (the "Act"), each of the Reporting Persons may be deemed to be the beneficial owner of the securities reported herein only to the extent of its pecuniary interest therein. Pursuant to Rule 16a-1(a)(4) under the Act, this filing shall not be deemed an admission that any of the Reporting Persons is, for purposes of Section 16 of the Act or otherwise, the beneficial owner of any securities reported herein in excess of such amount.

3. The shares are directly held by Aisling GP. On May 20, 2014, Aisling GP distributed 3,528 shares of Common Stock that it received in the Distribution to its partners and members other than Messrs. Schiff, Purcell and Elms.

4. The shares are directly held by Andrew Schiff (including 66 shares of Common Stock received by a trust for the benefit of Mr. Schiff's children).

5. The shares are directly held by Dennis Purcell (including 353 shares of Common Stock received by a trust for the benefit of Mr. Purcell's children and 116 shares of Common Stock received by Aisling Capital LLC, an entity owned by Mr. Purcell).

6. The shares are directly held by Steve Elms (including 361 shares of Common Stock received by a trust for the benefit of Mr. Elm's children).

7. This filing constitutes an exit filing for all Reporting Persons as they are no longer subject to Section 16 under the Act.

Remarks:

Exhibit List: 99.1 - Signatures of Joint Filers

	See Signatures on Exhibit	05/22/2014
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.